ZA923735B - Essential pure human parathyroid hormone - Google Patents

Essential pure human parathyroid hormone

Info

Publication number
ZA923735B
ZA923735B ZA923735A ZA923735A ZA923735B ZA 923735 B ZA923735 B ZA 923735B ZA 923735 A ZA923735 A ZA 923735A ZA 923735 A ZA923735 A ZA 923735A ZA 923735 B ZA923735 B ZA 923735B
Authority
ZA
South Africa
Prior art keywords
parathyroid hormone
human parathyroid
pure human
essential pure
essential
Prior art date
Application number
ZA923735A
Other languages
English (en)
Inventor
Dennis R Sindrey
R Sindrey Dennis
Original Assignee
Allelix Biopharma
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA923735(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allelix Biopharma, Glaxo Canada filed Critical Allelix Biopharma
Publication of ZA923735B publication Critical patent/ZA923735B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA923735A 1991-05-23 1992-05-22 Essential pure human parathyroid hormone ZA923735B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone

Publications (1)

Publication Number Publication Date
ZA923735B true ZA923735B (en) 1993-01-27

Family

ID=24840399

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923735A ZA923735B (en) 1991-05-23 1992-05-22 Essential pure human parathyroid hormone

Country Status (16)

Country Link
US (1) US5208041A (sv)
EP (1) EP0515228B1 (sv)
JP (1) JP2563726B2 (sv)
KR (1) KR970007755B1 (sv)
AT (1) ATE164394T1 (sv)
CA (1) CA2068438C (sv)
DE (1) DE69224858T2 (sv)
DK (1) DK0515228T3 (sv)
ES (1) ES2115642T3 (sv)
FI (1) FI106802B (sv)
HK (1) HK1004340A1 (sv)
IE (1) IE921672A1 (sv)
IL (3) IL119840A (sv)
NO (2) NO304190B1 (sv)
NZ (1) NZ242855A (sv)
ZA (1) ZA923735B (sv)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
AU8002994A (en) * 1993-10-27 1995-05-22 Chugai Seiyaku Kabushiki Kaisha Cure accelerator in chondroplasty
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
WO1999006563A1 (en) 1997-07-30 1999-02-11 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
DZ2873A1 (fr) 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
WO2000023594A1 (en) * 1998-10-22 2000-04-27 The General Hospital Corporation BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
WO2000032771A1 (en) 1998-11-30 2000-06-08 The General Hospital Corporation Pth1r and pth3r receptors, methods and uses thereof
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
WO2004028444A2 (en) * 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
TWI293563B (en) 2000-06-30 2008-02-21 Asubio Pharma Co Ltd Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
CA2454275C (en) * 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
EP1610813A4 (en) * 2003-03-19 2009-07-01 Gen Hospital Corp PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A)
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
EP1653985A4 (en) 2003-07-17 2009-08-05 Gen Hospital Corp CONSTRAINTS CONTAINING CONTAINING HORMONE PARATHYROID (PTH) ANALOGUES
EP1744683B1 (en) 2004-05-13 2016-03-16 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
EP1945245A2 (en) * 2005-11-10 2008-07-23 The Board of Control of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
JP2009545320A (ja) * 2006-08-04 2009-12-24 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン（ｐｔｈ）のポリペプチド誘導体
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
MX2010001612A (es) * 2007-08-09 2010-07-01 Usv Ltd Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34).
KR20120055653A (ko) * 2009-08-11 2012-05-31 바이오콘 리미티드 크로마토그래피 방법 및 그의 정제된 화합물
BR112012013725A2 (pt) 2009-12-07 2017-01-10 Univ Michigan Tech paratormônio de urso preto e métodos de usar o paratormônio de uso preto.
RU2604809C2 (ru) 2010-05-13 2016-12-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги паратиреоидного гормона и их применение
EP2719393B1 (en) * 2011-06-07 2020-10-21 Asahi Kasei Pharma Corporation Freeze-dried preparation containing high-purity pth and method for producing same
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
US20230190880A1 (en) 2020-03-30 2023-06-22 Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
WO1991005050A1 (en) * 1989-09-29 1991-04-18 Her Majesty In Right Of Canada As Represented By The National Research Council Of Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
NO2006013I1 (no) 2006-11-06
DE69224858D1 (de) 1998-04-30
FI922356A0 (fi) 1992-05-22
US5208041A (en) 1993-05-04
EP0515228A3 (sv) 1994-05-04
DK0515228T3 (da) 1998-09-28
CA2068438C (en) 1996-11-12
IL101829A (en) 1999-12-31
DE69224858T2 (de) 1998-07-23
NO922000D0 (no) 1992-05-21
IL119840A0 (en) 1997-03-18
IE921672A1 (en) 1992-12-02
AU639856B2 (en) 1993-08-05
EP0515228B1 (en) 1998-03-25
FI922356A (fi) 1992-11-24
NO922000L (no) 1992-11-24
HK1004340A1 (en) 1998-11-20
JPH0687897A (ja) 1994-03-29
JP2563726B2 (ja) 1996-12-18
NO2006013I2 (no) 2009-12-07
CA2068438A1 (en) 1992-11-24
AU1604992A (en) 1993-03-11
FI106802B (sv) 2001-04-12
KR970007755B1 (en) 1997-05-16
ES2115642T3 (es) 1998-07-01
NO304190B1 (no) 1998-11-09
EP0515228A2 (en) 1992-11-25
IL101829A0 (en) 1992-12-30
IL119840A (en) 2005-08-31
ATE164394T1 (de) 1998-04-15
NZ242855A (en) 1994-04-27

Similar Documents

Publication Publication Date Title
KR970007755B1 (en) Essential pure human parathyroid hormone
DE69405102D1 (en) Antikoerperfragmente in therapie
HUT44443A (en) Preparation and method for cleaning and disinfecting contact-lenses
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
IT8221194A0 (it) Procedimento e dispositivo per la deformazione dei corpi di lattine e dispositivo per l'esecuzione di questo procedimento.
IL97981A0 (en) Method for reducing carryover contamination in an amplification procedure
GB2181828B (en) Liquid-vapour contact method and apparatus
ATE72833T1 (de) Rinder-prowachstums- und -wachstumshormon.
GB2259138B (en) Minisatellite variant repeat (MVR-PRC) mapping
GR3006041T3 (sv)
EP0168030A3 (en) Contact type image sensor and driving method therefor
AU577692B2 (en) Lorgnette frame
EP0181009A3 (en) Image processing device and method for controlling the same
GB8820058D0 (en) Mosfet & fabrication method
EP0196405A3 (en) Color picture reader and method for operating the same
ZA868540B (en) Human-iysozym
GR851623B (sv)
IT8467198A1 (it) Metodo e dispositivo per il controllo dei processi di saldatura mediante l'analisi della luminosita' generata durante il processo.
HU900822D0 (en) Trichoderma-fungus and fungicid containing it
GB8904194D0 (en) Method for measuring and controlling ozone concentration
EP0205726A3 (en) Image controlling method and device for carrying out the same
JPS6465184A (en) Method for sealing epoxy fluorinated carbon
GR930300014T1 (en) Burst-test
GB8722469D0 (en) Protein assay device & method
PL273538A1 (en) Method for controlling operation of current sopurce in a magnetic-powder defectoscope excitation device and a system for controlling the current source of a magnetic-powder defectoscope excitation device